Novel prophylactic anticoagulation scoring tool helps stratify patients following lower limb trauma
1. The 3-month symptomatic venous thromboembolism rate was 0.7% in patients with TRiP(cast) score < 7 and not receiving anticoagulation. ...
Tag: venous thromboembolism
#VisualAbstract: Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical Patients
Click to read the study in NEJM ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
Indefinite anticoagulation for unprovoked venous thromboembolism is not cost-effective
1. In this Markov modeling study, indefinite anticoagulation for first unprovoked venous thromboembolism (VTE) cost $16,014 more per person than ...
Effect of thromboprophylaxis following COVID-19 hospitalization unclear
1. In this randomized controlled trial, the effects of thromboprophylaxis on clinical outcomes after coronavirus disease 2019 (COVID-19) hospitalization were ...
Low-dose low-molecular weight heparin comparable to intermediate-dose for risk of venous thromboembolism in peripartum women
1. Risk of venous thromboembolism in the antepartum and postpartum period was comparable between the intermediate- and low-dose low-molecular weight ...
#VisualAbstract: Aspirin associated with significantly higher rate of symptomatic venous thromboembolism compared to enoxaparin in patients undergoing hip or knee arthroplasty
1. In this random1. In this randomized controlled trial that included 9711 patients undergoing hip or knee arthroplasty, treatment ...
Hospitalization due to COVID-19 increases risk of venous thromboembolism compared to hospitalization due to influenza
1. Patients hospitalized due to COVID-19 had a higher risk of developing a venous thromboembolism within 90 days of admission ...
SARS-CoV-2 infection during pregnancy associated with severe maternal morbidity, preterm birth, and venous thromboembolism
1. In a large longitudinal, population-based cohort study, SARS-CoV-2 infection during pregnancy was associated with severe maternal morbidity, preterm birth, ...
#VisualAbstract: Rivaroxaban prophylaxis improves clinical outcomes in high-risk patients hospitalized with COVID-19
1. The primary efficacy outcome of symptomatic and asymptomatic venous thromboembolism was significantly lower in the rivaroxaban group (3.14%) compared ...
Aspirin use was not effective at reducing mortality in patients hospitalized with COVID-19
1. There was no significant difference in all-cause mortality and need for invasive mechanical ventilation among patients assigned to aspirin ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
